Home/Amsel Medical/James A. Heinz, MSL
JA

James A. Heinz, MSL

Chief Executive Officer

Amsel Medical

Amsel Medical Pipeline

DrugIndicationPhase
SCureClamp iDOT for Vascular SurgeryOcclusion of vessels for treatment of venous disease (e.g., varicose veins)Commercial
SCureClamp iDOT for TraumaTemporary clamping for non-compressible/junctional hemorrhage (military & civilian trauma)Development
SCureClamp iDOT for General SurgeryLigation of vessels/ducts in bariatric, cardiac, oncology, and other surgeriesCommercial